Biocon Statistics
Total Valuation
Biocon has a market cap or net worth of INR 473.59 billion. The enterprise value is 672.24 billion.
Market Cap | 473.59B |
Enterprise Value | 672.24B |
Important Dates
The last earnings date was Wednesday, July 30, 2025.
Earnings Date | Jul 30, 2025 |
Ex-Dividend Date | Jul 4, 2025 |
Share Statistics
Biocon has 1.33 billion shares outstanding. The number of shares has increased by 0.24% in one year.
Current Share Class | 1.33B |
Shares Outstanding | 1.33B |
Shares Change (YoY) | +0.24% |
Shares Change (QoQ) | +0.61% |
Owned by Insiders (%) | 56.00% |
Owned by Institutions (%) | 24.38% |
Float | 583.07M |
Valuation Ratios
The trailing PE ratio is 110.62 and the forward PE ratio is 55.11. Biocon's PEG ratio is 1.40.
PE Ratio | 110.62 |
Forward PE | 55.11 |
PS Ratio | 3.00 |
PB Ratio | 1.71 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 1.40 |
Enterprise Valuation
EV / Earnings | 174.61 |
EV / Sales | 4.26 |
EV / EBITDA | 20.46 |
EV / EBIT | 41.45 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.66 |
Debt / EBITDA | 5.59 |
Debt / FCF | n/a |
Interest Coverage | 1.75 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 2.31% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 9.67M |
Profits Per Employee | 235,979 |
Employee Count | 16,315 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Biocon has paid 1.81 billion in taxes.
Income Tax | 1.81B |
Effective Tax Rate | 21.62% |
Stock Price Statistics
The stock price has increased by +5.15% in the last 52 weeks. The beta is 0.23, so Biocon's price volatility has been lower than the market average.
Beta (5Y) | 0.23 |
52-Week Price Change | +5.15% |
50-Day Moving Average | 367.55 |
200-Day Moving Average | 350.70 |
Relative Strength Index (RSI) | 40.55 |
Average Volume (20 Days) | 4,095,074 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biocon had revenue of INR 157.71 billion and earned 3.85 billion in profits. Earnings per share was 3.21.
Revenue | 157.71B |
Gross Profit | 95.31B |
Operating Income | 16.22B |
Pretax Income | 8.38B |
Net Income | 3.85B |
EBITDA | 32.26B |
EBIT | 16.22B |
Earnings Per Share (EPS) | 3.21 |
Balance Sheet
The company has 45.65 billion in cash and 183.62 billion in debt, giving a net cash position of -137.97 billion or -103.39 per share.
Cash & Cash Equivalents | 45.65B |
Total Debt | 183.62B |
Net Cash | -137.97B |
Net Cash Per Share | -103.39 |
Equity (Book Value) | 277.13B |
Book Value Per Share | 180.66 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 60.43%, with operating and profit margins of 10.28% and 2.44%.
Gross Margin | 60.43% |
Operating Margin | 10.28% |
Pretax Margin | 5.31% |
Profit Margin | 2.44% |
EBITDA Margin | 20.46% |
EBIT Margin | 10.28% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.14%.
Dividend Per Share | 0.50 |
Dividend Yield | 0.14% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.24% |
Shareholder Yield | -0.09% |
Earnings Yield | 0.81% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on June 12, 2019. It was a forward split with a ratio of 2.
Last Split Date | Jun 12, 2019 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |